USD 51.0
(-5.35%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 486.67 Million USD | 163.66% |
2023 | 184.58 Million USD | 1.31% |
2022 | 182.2 Million USD | -16.32% |
2021 | 217.74 Million USD | 3.23% |
2020 | 210.93 Million USD | 2.13% |
2019 | 206.52 Million USD | -7.55% |
2018 | 223.38 Million USD | -18.43% |
2017 | 273.86 Million USD | 22.17% |
2016 | 224.17 Million USD | 0.68% |
2015 | 222.65 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 186.17 Million USD | 0.86% |
2024 FY | 486.67 Million USD | 163.66% |
2024 Q4 | 486.67 Million USD | -1.49% |
2024 Q3 | 494.06 Million USD | 114.34% |
2024 Q2 | 230.5 Million USD | 23.81% |
2023 Q1 | 180.4 Million USD | -0.99% |
2023 FY | 184.58 Million USD | 1.31% |
2023 Q4 | 184.58 Million USD | 8.18% |
2023 Q3 | 170.62 Million USD | -7.86% |
2023 Q2 | 185.18 Million USD | 2.65% |
2022 Q3 | 185.48 Million USD | -6.76% |
2022 Q1 | 215.77 Million USD | -0.91% |
2022 Q4 | 182.2 Million USD | -1.77% |
2022 FY | 182.2 Million USD | -16.32% |
2022 Q2 | 198.91 Million USD | -7.81% |
2021 Q1 | 213.36 Million USD | 1.15% |
2021 FY | 217.74 Million USD | 3.23% |
2021 Q4 | 217.74 Million USD | 0.67% |
2021 Q3 | 216.3 Million USD | -1.13% |
2021 Q2 | 218.77 Million USD | 2.54% |
2020 Q3 | 213.8 Million USD | 4.12% |
2020 Q2 | 205.33 Million USD | -4.04% |
2020 Q1 | 213.97 Million USD | -1.15% |
2020 FY | 210.93 Million USD | 2.13% |
2020 Q4 | 210.93 Million USD | -1.34% |
2019 Q2 | 200.71 Million USD | -0.54% |
2019 FY | 206.52 Million USD | -7.55% |
2019 Q3 | 206.52 Million USD | 2.9% |
2019 Q4 | 216.47 Million USD | 4.82% |
2019 Q1 | 201.79 Million USD | -1.73% |
2018 Q3 | 223.38 Million USD | -6.56% |
2018 FY | 223.38 Million USD | -18.43% |
2018 Q4 | 205.34 Million USD | -8.08% |
2018 Q2 | 239.06 Million USD | 0.58% |
2018 Q1 | 237.67 Million USD | -5.58% |
2017 Q3 | 273.86 Million USD | 4.25% |
2017 Q4 | 251.72 Million USD | -8.09% |
2017 FY | 273.86 Million USD | 22.17% |
2017 Q1 | 293.87 Million USD | 27.26% |
2017 Q2 | 262.7 Million USD | -10.61% |
2016 Q3 | 224.17 Million USD | 0.0% |
2016 Q4 | 230.91 Million USD | 3.01% |
2016 FY | 224.17 Million USD | 0.68% |
2015 FY | 222.65 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Church & Dwight Co., Inc. | 4.71 Billion USD | 89.676% |
Colgate-Palmolive Company | 15.43 Billion USD | 96.847% |
The Clorox Company | 5.25 Billion USD | 90.746% |
Coty Inc. | 7.97 Billion USD | 93.899% |
The Estée Lauder Companies Inc. | 17.43 Billion USD | 97.208% |
Edgewell Personal Care Company | 2.2 Billion USD | 77.973% |
Grove Collaborative Holdings, Inc. | 132.62 Million USD | -266.97% |
Hims & Hers Health, Inc. | 97.15 Million USD | -400.916% |
Kimberly-Clark Corporation | 16.27 Billion USD | 97.01% |
Kenvue Inc. | 16.64 Billion USD | 97.075% |
Nu Skin Enterprises, Inc. | 984.49 Million USD | 50.566% |
The Procter & Gamble Company | 71.81 Billion USD | 99.322% |
Spectrum Brands Holdings, Inc. | 2.74 Billion USD | 82.239% |